Characteristics and Outcomes for Hospitalized Patients With Cutaneous T-Cell Lymphoma
Authors:
- 1 February 2023
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 159 (2) , 192-197
Abstract
Importance: Cutaneous T-cell lymphoma (CTCL) is a group of rare, complex cutaneous malignant neoplasms associated with significant disease burden on patients and the health care system. Currently, the population of patients with CTCL admitted to the hospital remains largely uncharacterized and poorly understood.Objective: To characterize the clinical characteristics, course of hospitalization, and mortality outcomes of an inpatient CTCL cohort.Design, Setting, and Participants: This multicenter retrospective cohort study reviewed medical records for adult patients (age ≥18 years) with a CTCL diagnosis per National Comprehensive Cancer Network guidelines admitted for inpatient hospitalization at 5 US academic medical centers with inpatient dermatology consult services and CTCL clinics between August 2016 and August 2020.Main Outcomes and Measures: Patient demographics, clinical history and findings, hospitalization courses, and mortality outcomes.Results: A total of 79 hospitalized patients with CTCL were identified, including 52 (70.3%) men and 22 (29.7%) women, with a median (IQR) age at hospitalization of 62.9 (27-92) years. The majority of admitted patients with CTCL were White (65 patients [82.3%]), had disease classified as mycosis fungoides (48 patients [61.5%]), and had advanced-stage disease (≥IIB, 70 patients [89.7%]). Most hospitalizations were complicated by infection (45 patients [57.0%]) and required intravenous antibiotic therapy (45 patients [57.0%]). In-hospital mortality occurred in 6 patients (7.6%) and was associated with higher body mass index (36.5 vs 25.3), history of thromboembolic disease (50.0% vs 12.3%), and diagnosis of sepsis on admission (66.7% vs 20.5%). At 1-year postdischarge, 36 patients (49.3%) patients had died, and mortality was associated with history of solid organ cancers (27.8% vs 10.8%), wound care as the reason for dermatology consultation (58.3% vs 24.3%), and presence of large cell transformation (58.3% vs 22.9%).Conclusions and Relevance: The findings of this cohort study improve the understanding of hospitalized patients with CTCL and lend valuable insight into identifying factors associated with both in-hospital and long-term mortality outcomes. This refined understanding of the inpatient CTCL population provides a foundation for larger, more robust studies to identify causal risk factors associated with mortality, development of prognostic scoring systems to estimate the probability of hospital mortality. Overall, the findings may prompt physicians caring for patients with CTCL to implement preventive strategies to diminish hospitalization and improve clinical management across this unique disease spectrum.Keywords
This publication has 14 references indexed in Scilit:
- Risk of venous thromboembolism in patients with mycosis fungoides and parapsoriasis: A Danish nationwide population-based cohort studyJournal of the American Academy of Dermatology, 2018
- A risk adjustment approach to estimating the burden of skin disease in the United StatesJournal of the American Academy of Dermatology, 2018
- Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical TrialsCancer Epidemiology, Biomarkers & Prevention, 2017
- Medical History, Lifestyle, Family History, and Occupational Risk Factors for Mycosis Fungoides and Sezary Syndrome: The InterLymph Non-Hodgkin Lymphoma Subtypes ProjectJNCI Monographs, 2014
- Incidence and survival patterns of cutaneous T-cell lymphomas in the United StatesLeukemia & Lymphoma, 2012
- Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sézary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging ProposalJournal of Clinical Oncology, 2010
- Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common CancersArchives of internal medicine (1960), 2006
- Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary SyndromeArchives of Dermatology, 2003
- Prognosis of Cancers Associated with Venous ThromboembolismNew England Journal of Medicine, 2000
- Infections Complicating Mycosis Fungoides and Sézary SyndromeJAMA, 1992